Fintel reports that on February 28, 2025, Piper Sandler upgraded their outlook for CAVA Group (NYSE:CAVA) from Neutral to ...

US stocks (^DJI, ^IXIC, ^GSPC) are trading higher Friday afternoon following a contentious meeting between US President Trump and Ukrainian President Volodymyr Zelenskyy. The exchange included sharp ...

Q4 2024 Management View Chirag Patel, Co-CEO, highlighted Amneal's "stellar financial performance" in 2024, citing double-digit revenue and adjusted EBITDA growth, reduction of net leverage below four ...

When does a rotation become a selloff? Investors may soon find out. For many investors, 2025 has been about switching—from ...

Piper Sandler upgraded CAVA Group (NYSE:CAVA) to an Overweight rating on Friday after having the restaurant stock slotted at ...

Q4 2024 Earnings Call Transcript February 27, 2025Ironwood Pharmaceuticals, Inc. misses on earnings expectations.

Piper Sandler analyst Rob Owens raised the firm’s price target on Elastic (ESTC) to $135 from $130 and keeps an Overweight rating on the ...

Piper Sandler analyst Matthew O’Brien maintained a Buy rating on TransMedics Group (TMDX – Research Report) today and set a price target of ...

Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Kymera Therapeutics (KYMR – Research Report) today and set a price target of ...

In a report released today, David Westenberg from Piper Sandler maintained a Buy rating on Natera (NTRA – Research Report), with a price target ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Structure Therapeutics, Inc. Sponsored ADR (GPCR – ...

Piper Sandler lowered the firm’s price target on Bloom Energy (BE) to $31 from $33 and keeps an Overweight rating on the shares. The firm says ...